Coronary Microvascular Remodeling

Information

  • Research Project
  • 6583442
  • ApplicationId
    6583442
  • Core Project Number
    F33HL072548
  • Full Project Number
    1F33HL072548-01
  • Serial Number
    72548
  • FOA Number
  • Sub Project Id
  • Project Start Date
    1/14/2003 - 21 years ago
  • Project End Date
    -
  • Program Officer Name
    COMMARATO, MICHAEL
  • Budget Start Date
    1/14/2003 - 21 years ago
  • Budget End Date
    1/13/2004 - 20 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    -
Organizations

Coronary Microvascular Remodeling

DESCRIPTION (provided by applicant): We will investigate the coronary arterial vasculature to determine the role of vascular remodeling in coronary vascular pathology. Inward remodeling results in a reduction of maximum vessel lumen diameter and compromises coronary blood flow. Vascular remodeling has been implicated in coronary flow complications associated with atherosclerosis, hypertension, restenosis and the pathologies of coronary bypass surgery. Our hypothesis is that vascular tone is the primary trigger for coronary arterial inward remodeling. Because many circulating factors found in vivo affect vascular tone, and because in vivo vascular hemodynamics are inherently complex, a novel in vitro system will be used that can simplify and separately examine contributing factors. Cannulated, perfused vessel segments cultured in the system maintain intact smooth muscle function and endothelium dependent dilation for up to fourteen days. Among other broader experimental objectives, the specific objective of this study to be undertaken during the course of my sabbatical is to determine the effect of conditions common to coronary artery disease on in vitro coronary vascular remodeling. Additionally, by conducting initial studies on ovarian resistance arteries, I also will undertake these objectives: to determine whether cyclic remodeling of ovarian resistance vessels occurs in vivo; and to optimize techniques for the culturing of ovarian resistance vessels.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    F33
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    50808
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:50808\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF AMSTERDAM
  • Organization Department
  • Organization DUNS
  • Organization City
    AMSTERDAM
  • Organization State
  • Organization Country
    NETHERLANDS
  • Organization Zip Code
  • Organization District
    NETHERLANDS